Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedDec 25, 2024
DataAggregated Company Financials
Companies29
  • 7D-0.4%
  • 3M-6.3%
  • 1Y-1.8%
  • YTD-5.2%

Over the last 7 days, the Pharma industry has remained flat. Furthermore, the industry has been flat for the past year as well. As for the next few years, earnings are expected to grow by 75% per annum.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 25 Dec 2024SEK 50.1bSEK 4.4b-SEK 615,881,387.68125.3x-81.4x11.3x
Fri, 22 Nov 2024SEK 49.3bSEK 4.4b-SEK 620,919,437.28123.9x-79.4x11.1x
Sun, 20 Oct 2024SEK 53.9bSEK 4.3b-SEK 677,083,649.86136.8x-79.6x12.6x
Tue, 17 Sep 2024SEK 67.2bSEK 5.9b-SEK 1,169,939,093.91176.5x-57.5x11.4x
Thu, 15 Aug 2024SEK 67.9bSEK 5.9b-SEK 949,140,384.5886.4x-71.6x11.5x
Sat, 13 Jul 2024SEK 69.5bSEK 6.4b-SEK 835,140,932.6385.7x-83.2x10.8x
Mon, 10 Jun 2024SEK 61.9bSEK 6.5b-SEK 919,041,229.5276.6x-67.4x9.6x
Wed, 08 May 2024SEK 49.2bSEK 6.3b-SEK 892,626,337.9566.3x-55.2x7.8x
Fri, 05 Apr 2024SEK 51.8bSEK 6.2b-SEK 1,038,133,083.1576.7x-49.9x8.3x
Sun, 03 Mar 2024SEK 47.5bSEK 6.2b-SEK 1,038,034,450.5779.1x-45.8x7.6x
Tue, 30 Jan 2024SEK 69.2bSEK 9.5b-SEK 1,181,818,214.0065.8x-58.5x7.3x
Thu, 28 Dec 2023SEK 68.6bSEK 9.4b-SEK 1,184,193,662.0063.6x-57.9x7.3x
Sat, 25 Nov 2023SEK 61.2bSEK 9.5b-SEK 1,179,301,501.0054.4x-51.9x6.5x
Mon, 23 Oct 2023SEK 50.7bSEK 9.2b-SEK 1,143,007,405.00104.7x-44.3x5.5x
Wed, 20 Sep 2023SEK 50.9bSEK 9.2b-SEK 1,177,929,327.00133.5x-43.2x5.5x
Fri, 18 Aug 2023SEK 50.7bSEK 8.9b-SEK 1,410,614,455.0087.7x-35.9x5.7x
Sun, 16 Jul 2023SEK 48.2bSEK 8.4b-SEK 1,693,182,186.0081.3x-28.5x5.8x
Tue, 13 Jun 2023SEK 48.1bSEK 8.4b-SEK 1,706,789,782.0079.5x-28.2x5.8x
Thu, 11 May 2023SEK 49.0bSEK 8.1b-SEK 1,812,033,024.0084.9x-27.1x6x
Sat, 08 Apr 2023SEK 46.4bSEK 8.0b-SEK 1,793,933,339.0088x-25.8x5.8x
Mon, 06 Mar 2023SEK 45.0bSEK 8.0b-SEK 1,803,965,361.0091x-24.9x5.7x
Wed, 01 Feb 2023SEK 47.3bSEK 7.3b-SEK 1,966,272,305.00298.4x-24.1x6.5x
Fri, 30 Dec 2022SEK 48.2bSEK 7.3b-SEK 1,910,722,468.00294.7x-25.2x6.6x
Sun, 27 Nov 2022SEK 50.2bSEK 7.2b-SEK 1,921,188,124.0041.4x-26.1x7x
Tue, 25 Oct 2022SEK 48.4bSEK 7.0b-SEK 1,754,826,134.0047.6x-27.6x6.9x
Thu, 22 Sep 2022SEK 50.1bSEK 7.0b-SEK 1,739,665,174.0049x-28.8x7.2x
Sat, 20 Aug 2022SEK 53.3bSEK 6.9b-SEK 1,543,624,850.0040.1x-34.5x7.7x
Mon, 18 Jul 2022SEK 49.8bSEK 6.0b-SEK 1,414,388,648.0043.2x-35.2x8.3x
Wed, 15 Jun 2022SEK 50.6bSEK 5.9b-SEK 1,505,666,101.0041.6x-33.6x8.5x
Fri, 13 May 2022SEK 48.7bSEK 5.5b-SEK 1,271,129,557.0035.2x-38.3x8.8x
Sun, 10 Apr 2022SEK 56.0bSEK 5.5b-SEK 1,335,083,342.0040x-41.9x10.1x
Tue, 08 Mar 2022SEK 47.5bSEK 5.4b-SEK 1,389,013,613.0030.6x-34.2x8.7x
Thu, 03 Feb 2022SEK 49.6bSEK 5.3b-SEK 1,044,335,217.0076.8x-47.4x9.4x
Sat, 01 Jan 2022SEK 58.5bSEK 5.5b-SEK 1,100,183,162.00125x-53.2x10.7x
Price to Earnings Ratio

-53.2x


Total Market Cap: SEK 58.5bTotal Earnings: -SEK 1,100,183,162.00Total Revenue: SEK 5.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -44.8x202220232024
Current Industry PE
  • Investors are optimistic on the Swedish Pharmaceuticals industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 8.1x is lower than the industry's current PS ratio of 11.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 6.6% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-1.97%
Healthcare1.44%
Pharma-0.36%
Pharma-0.36%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CAMX CamurusSEK 567.000.4%
+SEK 147.0m		8.8%PE125.3x
IBT B Infant Bacterial TherapeuticsSEK 56.004.9%
+SEK 35.0m		-37.9%PS150879.9x
MOB Moberg PharmaSEK 10.502.7%
+SEK 13.1m		-22.2%PS55.8x
ERMA Enorama PharmaSEK 3.067.0%
+SEK 12.1m		4.8%PS13.9x
CLBIO Corline BiomedicalSEK 8.866.5%
+SEK 11.6m		-37.4%PS8.1x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CINPHA

SEK 20.05

Cinclus Pharma Holding

7D

-6.6%

1Y

n/a

Cinclus Pharma Holding (STO:CINPHA) Is In A Good Position To Deliver On Growth Plans

Dec 22
Cinclus Pharma Holding (STO:CINPHA) Is In A Good Position To Deliver On Growth Plans

CSMED

DKK 1.13

CS Medica

7D

-80.7%

1Y

-68.3%

ORX

SEK 17.80

Orexo

7D

-18.9%

1Y

9.5%

A Piece Of The Puzzle Missing From Orexo AB (publ)'s (STO:ORX) 105% Share Price Climb

Dec 20
A Piece Of The Puzzle Missing From Orexo AB (publ)'s (STO:ORX) 105% Share Price Climb

DICOT

SEK 0.22

Dicot Pharma

7D

2.3%

1Y

-24.8%

MOB

SEK 10.50

Moberg Pharma

7D

2.7%

1Y

-22.2%

CAMX

SEK 567.00

Camurus

7D

0.4%

1Y

8.8%

Camurus AB (publ)'s (STO:CAMX) P/S Is On The Mark

Dec 07
Camurus AB (publ)'s (STO:CAMX) P/S Is On The Mark

IBT B

SEK 56.00

Infant Bacterial Therapeutics

7D

4.9%

1Y

-37.9%

Will Infant Bacterial Therapeutics (STO:IBT B) Spend Its Cash Wisely?

Dec 05
Will Infant Bacterial Therapeutics (STO:IBT B) Spend Its Cash Wisely?

ACUC

SEK 0.74

AcuCort

7D

10.1%

1Y

89.3%

SECARE

SEK 48.96

Swedencare

7D

-2.1%

1Y

-19.7%

IRLAB A

SEK 11.05

IRLAB Therapeutics

7D

-1.8%

1Y

72.7%

ERMA

SEK 3.06

Enorama Pharma

7D

7.0%

1Y

4.8%

ENZY

SEK 1.63

Enzymatica

7D

-4.1%

1Y

-55.9%

CLBIO

SEK 8.86

Corline Biomedical

7D

6.5%

1Y

-37.4%

DBP B

SEK 0.39

Double Bond Pharmaceutical International

7D

-19.8%

1Y

-52.3%

FLERIE

SEK 46.92

Flerie

7D

-2.7%

1Y

n/a

CESSA

DKK 12.70

Cessatech

7D

3.3%

1Y

136.1%